Related Experiment Video

Updated: Oct 10, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

Chagas' heart disease

A Rassi1, A Rassi, W C Little

  • 1Section of Cardiology, Anis Rassi Hospital, Goiânia, Goias, Brazil.

Clinical Cardiology
|December 29, 2000
PubMed

Insights

Chagas' disease, caused by Trypanosoma cruzi, affects millions in Latin America. Early diagnosis and treatment with benznidazole, alongside cardiac management, are crucial for improving patient outcomes and preventing transmission.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Parasitology

Background:

  • Chagas' disease is a significant public health concern in Latin America, caused by the protozoan parasite Trypanosoma cruzi.
  • Transmission occurs via infected insect vectors or nonvectorial routes like blood transfusions.
  • Chronic infection often leads to severe cardiac complications decades after initial exposure.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and management of Chagas' disease, with a focus on cardiac involvement.
  • To highlight the challenges posed by migration and potential transmission in non-endemic regions.
  • To discuss current and potential therapeutic strategies for Chagas' heart disease.

Main Methods:

  • Review of existing literature on Chagas' disease epidemiology, clinical presentation, and treatment.
  • Analysis of diagnostic criteria, including serologic tests and clinical manifestations.
  • Evaluation of therapeutic options for both acute and chronic phases of the infection.

Main Results:

  • Chagas' heart disease can manifest as arrhythmias, heart failure, and sudden death.
  • An estimated 16–18 million individuals are infected in Latin America.
  • Misdiagnosis in immigrant populations and transfusion-related transmission are critical concerns.

Conclusions:

  • Early diagnosis and treatment with benznidazole are effective for initial infections and may benefit chronic cases.
  • Management of cardiac involvement using medications like amiodarone, ACE inhibitors, and pacemakers can improve survival.
  • Increased awareness and diagnostic efforts are essential to address Chagas' disease in non-endemic countries.

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...